메뉴 건너뛰기




Volumn 17, Issue 2, 2013, Pages 294-303

Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis- stimulating agents

Author keywords

Anemia; Chronic kidney disease; Erythropoietin; Left ventricular hypertrophy; Prognosis; Reverse epidemiology

Indexed keywords

ANTIANEMIC AGENT; C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; BIOLOGICAL MARKER;

EID: 84891382885     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0705-4     Document Type: Article
Times cited : (11)

References (45)
  • 4
    • 0032572913 scopus 로고    scopus 로고
    • The effect of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    • Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effect of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339: 584-90.
    • (1998) N Engl J Med , vol.339 , pp. 584-590
    • Besarab, A.1    Bolton, W.K.2    Browne, J.K.3    Egrie, J.C.4    Nissenson, A.R.5    Okamoto, D.M.6
  • 5
    • 0030636320 scopus 로고    scopus 로고
    • Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
    • Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience. 1997;76:105-16.
    • (1997) Neuroscience , vol.76 , pp. 105-116
    • Morishita, E.1    Masuda, S.2    Nagao, M.3    Yasuda, Y.4    Sasaki, R.5
  • 6
    • 6344225691 scopus 로고    scopus 로고
    • Erythropoietin receptor expression in adult rat cardiomyocytes in associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury
    • Wright GL, Hanlon P, Amin K, Steenbergen C, Murphy E, Arcasoy MO. Erythropoietin receptor expression in adult rat cardiomyocytes in associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J. 2004;18:1031-3.
    • (2004) FASEB J , vol.18 , pp. 1031-1033
    • Wright, G.L.1    Hanlon, P.2    Amin, K.3    Steenbergen, C.4    Murphy, E.5    Arcasoy, M.O.6
  • 7
    • 0033029430 scopus 로고    scopus 로고
    • Human, rat, and mouse kidney cells express functional erythropoietin receptors
    • Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999;55:808-20.
    • (1999) Kidney Int , vol.55 , pp. 808-820
    • Westenfelder, C.1    Biddle, D.L.2    Baranowski, R.L.3
  • 8
    • 4644310308 scopus 로고    scopus 로고
    • Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells
    • Beleslin-Cokic BB, Cokic VP, Yu X, Weksler BB, Schechter AN, Noguchi CT. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood. 2004;104:2073-80.
    • (2004) Blood , vol.104 , pp. 2073-2080
    • Beleslin-Cokic, B.B.1    Cokic, V.P.2    Yu, X.3    Weksler, B.B.4    Schechter, A.N.5    Noguchi, C.T.6
  • 9
    • 0037133191 scopus 로고    scopus 로고
    • Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury
    • Celik M, Gökmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA. 2002;99:2258-63.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 2258-2263
    • Celik, M.1    Gökmen, N.2    Erbayraktar, S.3    Akhisaroglu, M.4    Konakc, S.5    Ulukus, C.6
  • 10
    • 0037447256 scopus 로고    scopus 로고
    • Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
    • Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA. 2003;100:4802-6.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 4802-4806
    • Calvillo, L.1    Latini, R.2    Kajstura, J.3    Leri, A.4    Anversa, P.5    Ghezzi, P.6
  • 12
    • 4344626952 scopus 로고    scopus 로고
    • Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure
    • Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation. 2004;24:1006-12.
    • (2004) Circulation , vol.24 , pp. 1006-1012
    • Bahlmann, F.H.1    Song, R.2    Boehm, S.M.3    Mengel, M.4    Von Wasielewski, R.5    Lindschau, C.6
  • 14
    • 0028939185 scopus 로고
    • Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
    • Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186-92.
    • (1995) Kidney Int , vol.47 , pp. 186-192
    • Foley, R.N.1    Parfrey, P.S.2    Harnett, J.D.3    Kent, G.M.4    Martin, C.J.5    Murray, D.C.6
  • 15
    • 0029928215 scopus 로고    scopus 로고
    • Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
    • Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27: 347-54.
    • (1996) Am J Kidney Dis , vol.27 , pp. 347-354
    • Levin, A.1    Singer, J.2    Thompson, C.R.3    Ross, H.4    Lewis, M.5
  • 18
    • 0026799396 scopus 로고
    • Reduced capillary density in the myocardium of uremic rats - A stereological study
    • Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G. Reduced capillary density in the myocardium of uremic rats-a stereological study. Kidney Int. 1992;42:1079-85.
    • (1992) Kidney Int , vol.42 , pp. 1079-1085
    • Amann, K.1    Wiest, G.2    Zimmer, G.3    Gretz, N.4    Ritz, E.5    Mall, G.6
  • 19
    • 0030357960 scopus 로고    scopus 로고
    • Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effects of ramipril, nifedipine and moxonidine
    • Torning J, Amann K, Ritz E, Nichols C, Zeier M, Mall G. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol. 1996;7: 667-75.
    • (1996) J Am Soc Nephrol , vol.7 , pp. 667-675
    • Torning, J.1    Amann, K.2    Ritz, E.3    Nichols, C.4    Zeier, M.5    Mall, G.6
  • 20
    • 0023947182 scopus 로고
    • Myocardial interstitial fibrosis in experimental uremia: Implications for cardiac compliance
    • Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E. Myocardial interstitial fibrosis in experimental uremia: implications for cardiac compliance. Kidney Int. 1988;33: 804-11.
    • (1988) Kidney Int , vol.33 , pp. 804-811
    • Mall, G.1    Rambausek, M.2    Neumeister, A.3    Kollmar, S.4    Vetterlein, F.5    Ritz, E.6
  • 21
    • 23644439061 scopus 로고    scopus 로고
    • Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
    • Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005; 115:2108-18.
    • (2005) J Clin Invest , vol.115 , pp. 2108-2118
    • Shiojima, I.1    Sato, K.2    Izumiya, Y.3    Schiekofer, S.4    Ito, M.5    Liao, R.6
  • 22
    • 33646149385 scopus 로고    scopus 로고
    • Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload
    • Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension. 2006;47:887-93.
    • (2006) Hypertension , vol.47 , pp. 887-893
    • Izumiya, Y.1    Shiojima, I.2    Sato, K.3    Sawyer, D.B.4    Colucci, W.S.5    Walsh, K.6
  • 23
    • 33947520124 scopus 로고    scopus 로고
    • p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
    • Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature. 2007;446:444-8.
    • (2007) Nature , vol.446 , pp. 444-448
    • Sano, M.1    Minamino, T.2    Toko, H.3    Miyauchi, H.4    Orimo, M.5    Qin, Y.6
  • 24
    • 34247201113 scopus 로고    scopus 로고
    • Protective role of endogeneous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice
    • Asaumi Y, Kagaya Y, Takeda M, Yamaguchi N, Tada H, Ito K, et al. Protective role of endogeneous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice. Circulation. 2007;115:2022-32.
    • (2007) Circulation , vol.115 , pp. 2022-2032
    • Asaumi, Y.1    Kagaya, Y.2    Takeda, M.3    Yamaguchi, N.4    Tada, H.5    Ito, K.6
  • 25
    • 0024324631 scopus 로고
    • Impact of left ventricular hypertrophy on survival in end-stage renal disease
    • Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286-90.
    • (1989) Kidney Int , vol.36 , pp. 286-290
    • Silberberg, J.S.1    Barre, P.E.2    Prichard, S.S.3    Sniderman, A.D.4
  • 28
    • 72049089062 scopus 로고    scopus 로고
    • Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD
    • Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. J Am Soc Nephrol. 2009;20:2651-60.
    • (2009) J Am Soc Nephrol , vol.20 , pp. 2651-2660
    • Eckardt, K.U.1    Scherhag, A.2    Macdougall, I.C.3    Tsakiris, D.4    Clyne, N.5    Locatelli, F.6
  • 30
    • 0022588019 scopus 로고
    • Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
    • Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.
    • (1986) Am J Cardiol , vol.57 , pp. 450-458
    • Devereux, R.B.1    Alonso, D.R.2    Lutas, E.M.3    Gottlieb, G.J.4    Campo, E.5    Sachs, I.6
  • 32
    • 0015043899 scopus 로고
    • Left ventricular volumes and ejection fractions by echocardiography
    • Pombo JF, Troy BL, Russell RO Jr. Left ventricular volumes and ejection fractions by echocardiography. Circulation. 1971;43: 480-90.
    • (1971) Circulation , vol.43 , pp. 480-490
    • Pombo, J.F.1    Troy, B.L.2    Russell Jr., R.O.3
  • 34
    • 77956888457 scopus 로고
    • Partial residuals for the proportional hazards model
    • Schoenfeld D. Partial residuals for the proportional hazards model. Biometrika. 1982;69:51-5.
    • (1982) Biometrika , vol.69 , pp. 51-55
    • Schoenfeld, D.1
  • 36
    • 69249118530 scopus 로고    scopus 로고
    • Prescription of antihypertensive agents to haemodialysis patients: Time trend and associations with patients' characteristics, country and survival in the DOPPS
    • Lopes AA, Bragg-Gresham JL, Ramirez SP, Andreucci VE, Akiba T, Saito A, et al. Prescription of antihypertensive agents to haemodialysis patients: time trend and associations with patients' characteristics, country and survival in the DOPPS. Nephrol Dial Transplant. 2009;24:2809-16.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 2809-2816
    • Lopes, A.A.1    Bragg-Gresham, J.L.2    Ramirez, S.P.3    Andreucci, V.E.4    Akiba, T.5    Saito, A.6
  • 37
    • 46849093410 scopus 로고    scopus 로고
    • Beta-blockers for coronary heart disease in chronic kidney disease
    • Chonchol M, Benderly M, Goldbourt U. Beta-blockers for coronary heart disease in chronic kidney disease. Nephrol Dial Transplant. 2008;23:2274-9.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 2274-2279
    • Chonchol, M.1    Benderly, M.2    Goldbourt, U.3
  • 38
    • 0037337398 scopus 로고    scopus 로고
    • Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
    • Kalantar-Zadeh K, Block G, Humphreys MH, Kopple J. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793-808.
    • (2003) Kidney Int , vol.63 , pp. 793-808
    • Kalantar-Zadeh, K.1    Block, G.2    Humphreys, M.H.3    Kopple, J.4
  • 41
    • 68349150378 scopus 로고    scopus 로고
    • Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse
    • Shushakova N, Park JK, Menne J, Fliser D. Chronic erythropoietin treatment affects different molecular pathways of diabetic cardiomyopathy in mouse. Eur J Clin Invest. 2009;39:755-60.
    • (2009) Eur J Clin Invest , vol.39 , pp. 755-760
    • Shushakova, N.1    Park, J.K.2    Menne, J.3    Fliser, D.4
  • 42
    • 0033974161 scopus 로고    scopus 로고
    • Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
    • Hayashi T, Suzuki A, Shoji T, Togawa M, Okada N, Tsubakihara Y, et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis. 2000;35:250-6.
    • (2000) Am J Kidney Dis , vol.35 , pp. 250-256
    • Hayashi, T.1    Suzuki, A.2    Shoji, T.3    Togawa, M.4    Okada, N.5    Tsubakihara, Y.6
  • 43
    • 26944450575 scopus 로고    scopus 로고
    • Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dl
    • Ayus JC, Go AS, Valderrabano F, Verde E, Garcia de Vinuesa S, Achinger SG, et al. Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dl. Kidney Int. 2005;68:788-95.
    • (2005) Kidney Int , vol.68 , pp. 788-795
    • Ayus, J.C.1    Go, A.S.2    Valderrabano, F.3    Verde, E.4    De Garcia Vinuesa, S.5    Achinger, S.G.6
  • 44
    • 66449107161 scopus 로고    scopus 로고
    • Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: Meta-analysis
    • Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: meta-analysis. Clin J Am Soc Nephrol. 2009;4: 755-62.
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 755-762
    • Parfrey, P.S.1    Lauve, M.2    Latremouille-Viau, D.3    Lefebvre, P.4
  • 45
    • 75149198323 scopus 로고    scopus 로고
    • Dose TREAT give the boot to ESAs in the treatment of CKD anemia?
    • Singh AK. Dose TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol. 2010;21:2-6.
    • (2010) J Am Soc Nephrol , vol.21 , pp. 2-6
    • Singh, A.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.